Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / EBS - Emergent Biosolutions EPS misses by $1.23 misses on revenue

EBS - Emergent Biosolutions EPS misses by $1.23 misses on revenue

Emergent Biosolutions Inc.
Emergent Biosolutions (NYSE:EBS): Q2 Non-GAAP EPS of $0.33 misses by $1.23; GAAP EPS of $0.09 misses by $1.24. Revenue of $397.5M (+0.7% Y/Y) misses by $3.67M. Reaffirmed 2021 Outlook: Total revenues $1,700 - $1,900M; NARCAN® Nasal Spray $305 - $325M; Anthrax vaccines $280 - $310M; ACAM2000 $185 - $205M; CDMO services $765 - $875M; Adjusted EBITDA $620 - $720M; Adj. net income $395 - $470M; Gross margin 61% - 63%. Press Release

For further details see:

Emergent Biosolutions EPS misses by $1.23, misses on revenue
Stock Information
Company Name: Emergent Biosolutions Inc.
Stock Symbol: EBS
Market: NYSE
Website: emergentbiosolutions.com
Menu
EBS EBS Quote EBS Short EBS News EBS Articles EBS Message Board
Get EBS Alerts

News, Short Squeeze, Breakout and More Instantly...